Tesamorelin × aminousa.com — lab test, January 2025
BioRegen publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone. Click 'Verify' (top right), then enter COA Number + Validation Key from the COA
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10 mg
100% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.5 mg on both the label figure and the measured one.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Tesamorelin from aminousa.com, performed by BioRegen on January 20, 2025. Reported purity: 99.83%. Net content: 10 mg against 10 mg labeled (100% of label). Batch 25TESA10-0001. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Tesamorelin from aminousa.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 26TESA10-0003 | 7 Jan 2026 | freedomdiagnosticstesting.com | 99.138% | 121% | Unverified |
| 25TESA10-0003 | 6 Nov 2025 | freedomdiagnosticstesting.com | 98.964% | 109% | Unverified |
| 25TESA2-0003 | 22 Sept 2025 | BioRegen | 99.74% | 90% | Unverified |
| 25TESA5-0005 | 4 Sept 2025 | BioRegen | 99.9% | 107% | Unverified |
| 25TESA10-0002 | 23 Jul 2025 | BioRegen | 98.1% | 97% | Unverified |
| 25TESA5-0004 | 17 Jun 2025 | BioRegen | 99.78% | 93% | Unverified |
| 24TESA2-0002 | 28 Feb 2025 | BioRegen | 99.7% | 96% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion